Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2010
12/09/2010CA2764499A1 Interlaced method for treating cancer or a precancerous condition
12/09/2010CA2764480A1 Therapeutic and diagnostic molecules
12/09/2010CA2762206A1 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9
12/08/2010EP2259063A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
12/08/2010EP2258869A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258868A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258867A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258844A1 Tumour-specific bacterial promoter elements
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258841A1 Methods for treating pain
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258712A2 Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
12/08/2010EP2258395A1 Therapeutic agent for fibroid lung
12/08/2010EP2258166A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification
12/08/2010EP2257625A2 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof
12/08/2010EP2257587A1 Polymer derived from linear polyethylenimine for gene transfer
12/08/2010EP2257313A2 Ultra-small rnas as toll-like receptor-3 antagonists
12/08/2010EP2257308A2 Recombinant rhinovirus vectors
12/08/2010EP1848684B1 Ester-linked gemini surfactant compounds for use in gene therapy
12/08/2010EP1481095B1 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence
12/08/2010EP1276878B1 Reversible immortalization
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1913923B Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN1749397B Bi-recombinant active carrier vaccine of co-expression pig gyrate virus and foot and mouth disease virus
12/08/2010CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101906431A Expression vector of introne small interfering RNA, construction method and application thereof
12/08/2010CN101906418A Promoter for introducing gene into lymphocyte or blood cell and application thereof
12/08/2010CN101906417A shRNA for hepatitis B virus and recombinant adeno-associated virus vector treating vector carrying same
12/08/2010CN101906404A Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
12/08/2010CN101905024A Composition comprising and method of using angiopoietin-like protein 3 ANGPTl3
12/08/2010CN101905018A Recombinant fusion protein vaccine and attenuated live vector vaccine for treating and preventing helicobacter pylori (Hp) infection
12/08/2010CN101440359B Avian influenza viral vaccine and preparation thereof
12/08/2010CN101422605B Immunoloregulation type DNA vaccine capable of preventing Eimeria necatrix
12/08/2010CN101205544B Tumor targeting recombinant newcastle disease viruses and construction method thereof
12/08/2010CN101182548B 1 typerecombinant adeno related viral vaccine of HPV16 and method of producing the same
12/08/2010CN101096670B SiRNA interfering human a-fetoprotein gene and recombinant adenovirus
12/07/2010US7847091 target heat shock protein (hsp) 27 in vivo; antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA; injectable dosage unit form
12/07/2010US7847078 Phosphodiesterases (PDE); used for screening for Cushing's syndrome or bilateral adrenocortical hyperplasia (BAH)
12/07/2010US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
12/07/2010US7846910 degrades soluble and insoluble A beta so that it can prevent the accumulation of A beta in brain or reduce the accumulation; Alzheimer's disease and Down's syndrome
12/07/2010US7846909 Method and compositions for inhibiting MAGE protein interaction with KAP-1
12/07/2010US7846907 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
12/07/2010US7846729 Metabolically activated recombinant viral vectors and methods for their preparation and use
12/07/2010US7846679 Methods for detecting the presence of mutant mammalian presenilin protein
12/07/2010US7846667 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846436 For killing cancer cells; antimetabolites; solid phase synthesis
12/07/2010US7846429 Compositions and methods for elimination of unwanted cells
12/07/2010US7846428 Treating osteoarthritis via gene therapeutic plasmid comprising bone morphogenic protein sequences
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2262406C Gene therapy for congestive heart failure
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138675A1 Simian adenovirus 41 and uses thereof
12/02/2010WO2010137900A2 Selective infracted-tissue-targeting bacteria and use thereof
12/02/2010WO2010137890A2 Composition for improving the viability and proliferation ability of stem cells
12/02/2010WO2010137570A1 Anti-viral agent or an anti-cancer agent
12/02/2010WO2010137547A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
12/02/2010WO2010136536A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
12/02/2010WO2010065792A3 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305199 Therapeutic regimen for treating cancer
12/02/2010US20100305198 Cationic lipids
12/02/2010US20100305197 Conditionally Active Ribozymes And Uses Thereof
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100303857 Development of a preventive vaccine for filovirus infection in primates
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303768 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
12/02/2010US20100303716 Switchable nano-vehicle delivery systems, and methods for making and using them
12/02/2010CA2762203A1 Simian adenovirus 41 and uses thereof
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256190A1 Method of diagnosing risk of myocardial infarction
12/01/2010EP2256186A1 Myocardial grafts and cellular compositions
12/01/2010EP2255787A1 Synthetic glycolipid-containing liposomes
12/01/2010EP2254603A2 Methods for inhibiting six 1 and eya proteins
12/01/2010EP2254602A2 Continuous cell programming devices
12/01/2010EP2021485B1 Pseudotransposons and recombinant hyperactive transposition systems, derived from the mos-1 transposon
12/01/2010EP1427441B1 COMPOSITE SUPERIMMUNOGEN FOR BI-FUNCTIONAL VACCINE Tat-gp160 FOR USE IN THE TREATMENT OF AIDS
12/01/2010EP1414996B1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1727362B Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903529A SM-protein based secretion engineering
12/01/2010CN101903046A Constructs containing multiple expression cassettes for cancer therapy
12/01/2010CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
12/01/2010CN101899443A Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 870